Timeline
Rua Life Sciences
RUA Life Sciences sees higher first half revenue, and earnings breakeven
RUA Life Sciences spins out RUA Structural Heart and secures funding
More in Medtech & Diagnostics
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.